Author

Christopher D. Collier

Indiana University Melvin and Bren Simon Comprehensive Cancer CenterORCID 0000-0003-2639-4290Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Karen E. PollokiD· 2 shared Mohammad Reza SaadatzadehiD· 2 shared Aaron Cohen‐GadoliD· 1 shared Alyssa L. WalkeriD· 1 shared Brooke E. HickeyiD· 1 shared Christine A. BerryhilliD· 1 shared Christine A. PratilasiD· 1 shared Christopher M. DavisiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Karen E. PollokORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 5, 2026

ZNF423 depletion induces the integrated stress response and represents a potential vulnerability in NF1-associated MPNST

Sarah K. Morrow, Christine A. Berryhill, Emily E. White…·Steven P. Angus

This study shows ZNF423 depletion triggers the integrated stress response and sensitizes NF1-associated MPNST to chemotherapy, identifying it as a potential therapeutic target.

DOI 10.64898/2026.03.03.709360

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 22, 2025

Repurposing Romidepsin for Osteosarcoma: Screening FDA-Approved Oncology Drugs with Three-Dimensional Osteosarcoma Spheroids

Emily E. Seiden, Spencer M. Richardson, Leah A. Everitt…·Edward M. Greenfield

This paper identifies romidepsin as a promising repurposed drug for osteosarcoma using 3D spheroid models, showing efficacy against metastatic cells and outperforming other HDIs.

1 citation

humannon-human primate

𝕏 PostBluesky